Patent assignee · US · COMPANY

MESHABERASE, LLC

2Patents
2Active
2Granted
45Portfolio score

Filing activity: Oct 7, 2019 → Jun 2, 2021

Most-cited patents

PatentTitleAreaCited byStatus
US11844769B2 Use of cysteamine and derivatives thereof to suppress tumor metastases Human Necessities 0 Active
US11052057B2 Use of cysteamine and derivatives thereof to suppress tumor metastases Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.